Strong Pharmaceutical Company Business Model

Traditional pharmaceutical company sales of gold taken by the new model in the background of Yin Wei China's pharmaceutical industry has been improving policy development and legal change is not suited to modern demands, new competition in the industry marketing environment for pharmaceutical companies brought new challenges. In this context, pharmaceutical companies to explore new business model, pharmaceutical companies are the only way to survival and development. In the current theory and business practice, academic promotion model as a new model to replace with the gold takes on a sales model, gradually began to promote the application of the pharmaceutical business model. Compared with sales of gold, the academic model is the focus of drug itself, in this regard encourage enterprises to improve the quality of medicines through the development and technological innovation, on the other hand but also conducive to the provision of quality drugs to consumers. Academic innovation model as a representative of the pharmaceutical company created to promote business models and structures in the industrial chain, "Product + content" of the new model, while greatly improving the core competitiveness of enterprises, on the other hand, pharmaceutical manufacturing industry model of the whole industry sector has had a major impact, as the pharmaceutical companies in creating innovative model as a case for a comprehensive and systematic analysis is very theoretical and practical value.In this paper, selected pharmaceutical companies in creating new business models of academic promotion, as the object of this study, the use of the basic theory of its business model to a comprehensive value chain analysis, value chain, including suppliers, customer value chain, enterprise value chain, value chain channels, etc., on this basis the promotion of academic characteristics of this new business model and value. The point is that pharmaceutical companies based on creating value for customers, so in the usual production and management activities must collaborate effectively. On the one hand enterprises through market feedback information to understand the market demand, on the other hand enterprises through collaboration within the sector to improve efficiency in a timely manner to meet customer needs, in the course of its quality products as the intermediary must be sufficient to ensure that only so that it can create value for customers. Pharmaceutical companies created by the new model, for example, its in-depth analysis and a comprehensive exposition, and ultimately come to the purpose of creating value for customers decided to change the business model and promote the development of this conclusion, as a whole Pharmaceutical Industry business model to provide reference for the changes.